The opportunity exists for Wholesale Investors to express interest in Ora Pharm Limited (Ora Pharm)
Ora Pharm is ideally positioned to become the leading New Zealand supplier of high value, pharmaceutical grade medicinal cannabis products to meet rapidly growing international and domestic demand. Ora Pharm is secured a location in North Waikato that is ideally suited to growing cannabis, both indoors (year-round) and outdoors (seasonally). Using specialized greenhouses developed in the US but little-known in the Southern Hemisphere, Ora Pharm is preparing to own the most efficient and productive growing facilities for cannabis in New Zealand.
In a market with very high regulatory barriers to entry and competitors beginning to operate, Ora Pharm stands out as the only company with significant market experience and a strong US market platform to drive growth. Zoe Reece (CEO and Founder) and Stuart Wilcox (Executive Chairman and Head of International Business Development) bring a wealth of experience having previously held senior executive positions at Curaleaf, one of the largest and most respected cannabis corporation in North America with a market capitalisation of over US$11.5 billion.
Ora Pharm is seeking to raise up to NZ$11.5 million in equity capital through a Series A Funding Round from wholesale and institutional investors. The capital raised will support the expansion of cultivation capacity, develop processing and manufacturing capability and the freehold purchase of land.
For more information please refer to the Information Memorandum in the documents section.
To access further information and be put in contact with the arranger, Register Interest.